People · Operator
Named in public records as an officer, director or promoter · active 2011–2026 · Pharma, Pharmaceuticals, Biotech, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TwoStep Therapeutics, Inc. | — | Pharma | Series B | $27.6M | $80.9M | 2024 |
| resistanceBio, Inc. | — | Pharmaceuticals | Series A | $12.8M | $79.5M | 2024 |
| Talus Bioscience, Inc. | — | Biotech | Series A | $9.4M | $47.7M | 2024 |
| Pepper Bio, Inc. | — | Biotechnology | Seed | $4.8M | $1.7M | 2021 |
| Genome Compiler Corp | — | Other | Pre-Seed | $500K | $11.6M | 2011 |
Omri Amirav-Drory at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Omri Amirav-Drory on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Reese Jones | 1 | 3 |
| Matias Porras Paniagua | 1 | 1 |
| Caitlyn Miller | 1 | 1 |
| John Porras Prufeta | 1 | 1 |
| Lindsay Pino | 1 | 1 |
| Michelle Briscoe | 1 | 1 |
| Alex Federation | 1 | 1 |
| J. Seth Strattan | 1 | 1 |
| NICHOLAS GOLDNER | 1 | 1 |
| KYLE LAPHAM | 1 | 1 |
| CHRISTOPHER BULOW | 1 | 1 |
| Yu Hu | 1 | 1 |
| Samantha Dale Strasser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.